Filter by: patients
Home > Community Treatment Reports and Side Effects > Metformin-Pioglitazone Treatment Report
What is Metformin-Pioglitazone?

Metformin and pioglitazone is a combination of two oral diabetes medicines that help control blood sugar levels. It is for people with type 2 diabetes who do not use daily insulin injections. This medication is not for treating type 1 diabetes.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Diabetes Type 2 6 1 Efficacy_major
Other 4 2 Efficacy_moderate Efficacy_cant_tell

See all 9 patients currently taking Metformin-Pioglitazone

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 1
Moderate
 1
Mild
 0
None
 1

Commonly reported side effects, conditions, and hospitalizations associated with Metformin-Pioglitazone

Fatigue 1

Reported Dosages

  15 mg daily 500 mg daily 850 mg-15 mg daily 2 x 500 mg-15 mg daily 3 x 500 mg-15 mg daily 2 x 850 mg-15 mg daily 2,550 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Metformin-Pioglitazone (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 1   Doctor's advice: 50%
Side effects too severe 1   Side effects too severe: 50%

See all 2 patients who’ve stopped taking Metformin-Pioglitazone

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Metformin-Pioglitazone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Metformin-Pioglitazone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Metformin-Pioglitazone

Always
 1 33%
Usually
 0 0%
Sometimes
 1 33%
Never
 1 33%

Burden

Difficulty being on treatment

Burden of Metformin-Pioglitazone

Very
 0 0%
Somewhat
 1 33%
A little
 0 0%
Not at all
 2 67%

Cost

Paid out of pocket

Cost of Metformin-Pioglitazone

$200+
 0 0%
$100-199
 0 0%
$50-99
 1 100%
$25-49
 0 0%
< $25
 0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.